What Does Wall Street Think About Intuitive Surgical (ISRG) Stock?

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the Stocks That Will Make You Rich In 5 Years. Wall Street is bullish on the stock, and the analysts’ 12-month average price target of $597 reflects a 26.42% upside from the current level. Analysts have given a bullish sentiment on Intuitive Surgical, Inc. (NASDAQ:ISRG) after the company announced better-than-expected results for the fiscal second quarter of 2025.

The company grew its revenue by 21.40% year-over-year, topping the consensus by $87.21 million, while the EPS of $2.19 exceeded expectations by $0.27. On August 19, Leerink Partners analyst Mike Kratky reiterated a Buy rating on Intuitive Surgical, Inc. (NASDAQ:ISRG) with a price target of $593. Kratky noted the solid performance during the quarter to be driven by robust revenue growth across all segments and a notable increase in da Vinci system placements in the United States. More recently, on August 22, Adam Maeder from Piper Sandler also maintained a Buy rating on the stock, reiterating a price target of $595.

Looking ahead, management also updated the financial guidance for 2025 and now expects worldwide da Vinci procedure growth of around 15.5% to 17% during the year, up from 17% growth in 2024.

Intuitive Surgical, Inc. (NASDAQ:ISRG) develops and sells robotic-assisted surgical systems, including the da Vinci surgical system and the Ion endoluminal system.

While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.